Dose-dependent antagonism of spinal opioid receptor agonists by naloxone and naltrindole: additional evidence for δ-opioid receptor subtypes in the rat
- 12 May 1993
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 236 (1) , 89-96
- https://doi.org/10.1016/0014-2999(93)90230-f
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Design of peptidomimetic .delta. opioid receptor antagonists using the message-address conceptJournal of Medicinal Chemistry, 1990
- The selectivity of the opioid antagonist, naltrindole, for δ-opioid receptorsJournal of Pharmacy and Pharmacology, 1990
- Modulation of μ-mediated antinociception by δ agonists: characterization with antagonistsEuropean Journal of Pharmacology, 1989
- Modulation of μ-mediated antinociception by δ agonists in the mouse: selective potentiation of morphine and normorphine by [D-Pen2, D-Pen5]enkephalinEuropean Journal of Pharmacology, 1989
- Naltrindole, a highly selective and potent non-peptide δ opioid receptor antagonistEuropean Journal of Pharmacology, 1988
- Opioid δ-receptor involvement in supraspinal and spinal antinociception in miceBrain Research, 1987
- In vivo evidence for spinal delta-opiate receptor-operated antinociceptionNeuropeptides, 1986
- Minireview: Multiple MU opiate receptorsLife Sciences, 1986
- The analgesic efficacy of intrathecal d-ala2-d-leu5-enkephalin in cancer patients with chronic painPain, 1985
- Endogenous opioid peptides: multiple agonists and receptorsNature, 1977